Literature DB >> 22184412

Use of the chinchilla model for nasopharyngeal colonization to study gene expression by Moraxella catarrhalis.

Todd C Hoopman1, Wei Liu, Stephanie N Joslin, Christine Pybus, Jennifer L Sedillo, Maria Labandeira-Rey, Cassie A Laurence, Wei Wang, James A Richardson, Lauren O Bakaletz, Eric J Hansen.   

Abstract

Young adult chinchillas were atraumatically inoculated with Moraxella catarrhalis via the nasal route. Detailed histopathologic examination of nasopharyngeal tissues isolated from these M. catarrhalis-infected animals revealed the presence of significant inflammation within the epithelium. Absence of similar histopathologic findings in sham-inoculated animals confirmed that M. catarrhalis was exposed to significant host-derived factors in this environment. Twenty-four hours after inoculation, viable M. catarrhalis organisms were recovered from the nasal cavity and nasopharynx of the animals in numbers sufficient for DNA microarray analysis. More than 100 M. catarrhalis genes were upregulated in vivo, including open reading frames (ORFs) encoding proteins that are involved in a truncated denitrification pathway or in the oxidative stress response, as well as several putative transcriptional regulators. Additionally, 200 M. catarrhalis genes were found to be downregulated when this bacterium was introduced into the nasopharynx. These downregulated genes included ORFs encoding several well-characterized M. catarrhalis surface proteins including Hag, McaP, and MchA1. Real-time reverse transcriptase PCR (RT-PCR) was utilized as a stringent control to validate the results of in vivo gene expression patterns as measured by DNA microarray analysis. Inactivation of one of the genes (MC ORF 1550) that was upregulated in vivo resulted in a decrease in the ability of M. catarrhalis to survive in the chinchilla nasopharynx over a 3-day period. This is the first evaluation of global transcriptome expression by M. catarrhalis cells in vivo.

Entities:  

Mesh:

Year:  2011        PMID: 22184412      PMCID: PMC3294655          DOI: 10.1128/IAI.05918-11

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  67 in total

1.  Genome-directed primers for selective labeling of bacterial transcripts for DNA microarray analysis.

Authors:  A M Talaat; P Hunter; S A Johnston
Journal:  Nat Biotechnol       Date:  2000-06       Impact factor: 54.908

2.  Identification of gene products involved in the oxidative stress response of Moraxella catarrhalis.

Authors:  Todd C Hoopman; Wei Liu; Stephanie N Joslin; Christine Pybus; Chad A Brautigam; Eric J Hansen
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

3.  Expression of the Moraxella catarrhalis UspA1 protein undergoes phase variation and is regulated at the transcriptional level.

Authors:  E R Lafontaine; N J Wagner; E J Hansen
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

Review 4.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

5.  Comparative analysis and supragenome modeling of twelve Moraxella catarrhalis clinical isolates.

Authors:  Jeremiah J Davie; Josh Earl; Stefan P W de Vries; Azad Ahmed; Fen Z Hu; Hester J Bootsma; Kim Stol; Peter W M Hermans; Robert M Wadowsky; Garth D Ehrlich; John P Hays; Anthony A Campagnari
Journal:  BMC Genomics       Date:  2011-01-26       Impact factor: 3.969

Review 6.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

7.  Isolation and characterization of a novel IgD-binding protein from Moraxella catarrhalis.

Authors:  A Forsgren; M Brant; A Möllenkvist; A Muyombwe; H Janson; N Woin; K Riesbeck
Journal:  J Immunol       Date:  2001-08-15       Impact factor: 5.422

8.  Colonization of healthy children by Moraxella catarrhalis is characterized by genotype heterogeneity, virulence gene diversity and co-colonization with Haemophilus influenzae.

Authors:  Suzanne J C Verhaegh; Martine L Snippe; Foster Levy; Henri A Verbrugh; Vincent W V Jaddoe; Albert Hofman; Henriëtte A Moll; Alex van Belkum; John P Hays
Journal:  Microbiology       Date:  2010-09-16       Impact factor: 2.777

9.  DNA microarray analysis of differential gene expression in Borrelia burgdorferi, the Lyme disease spirochete.

Authors:  Andrew T Revel; Adel M Talaat; Michael V Norgard
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-05       Impact factor: 11.205

10.  A hag mutant of Moraxella catarrhalis strain O35E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities.

Authors:  Melanie M Pearson; Eric R Lafontaine; Nikki J Wagner; Joseph W St Geme; Eric J Hansen
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

View more
  13 in total

1.  Competition among Nasal Bacteria Suggests a Role for Siderophore-Mediated Interactions in Shaping the Human Nasal Microbiota.

Authors:  Reed M Stubbendieck; Daniel S May; Marc G Chevrette; Mia I Temkin; Evelyn Wendt-Pienkowski; Julian Cagnazzo; Caitlin M Carlson; James E Gern; Cameron R Currie
Journal:  Appl Environ Microbiol       Date:  2019-05-02       Impact factor: 4.792

2.  A Moraxella catarrhalis two-component signal transduction system necessary for growth in liquid media affects production of two lysozyme inhibitors.

Authors:  Stephanie N Joslin; Christine Pybus; Maria Labandeira-Rey; Amanda S Evans; Ahmed S Attia; Chad A Brautigam; Eric J Hansen
Journal:  Infect Immun       Date:  2014-10-13       Impact factor: 3.441

3.  Residence of Streptococcus pneumoniae and Moraxella catarrhalis within polymicrobial biofilm promotes antibiotic resistance and bacterial persistence in vivo.

Authors:  Antonia C Perez; Bing Pang; Lauren B King; Li Tan; Kyle A Murrah; Jennifer L Reimche; John T Wren; Stephen H Richardson; Uma Ghandi; W Edward Swords
Journal:  Pathog Dis       Date:  2014-02-03       Impact factor: 3.166

4.  Bacterium-generated nitric oxide hijacks host tumor necrosis factor alpha signaling and modulates the host cell cycle in vitro.

Authors:  Brian Mocca; Wei Wang
Journal:  J Bacteriol       Date:  2012-05-25       Impact factor: 3.490

Review 5.  Panel 6: Vaccines.

Authors:  Melinda M Pettigrew; Mark R Alderson; Lauren O Bakaletz; Stephen J Barenkamp; Anders P Hakansson; Kevin M Mason; Johanna Nokso-Koivisto; Janak Patel; Stephen I Pelton; Timothy F Murphy
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

Review 6.  Panel 4: Report of the Microbiology Panel.

Authors:  Stephen J Barenkamp; Tasnee Chonmaitree; Anders P Hakansson; Terho Heikkinen; Samantha King; Johanna Nokso-Koivisto; Laura A Novotny; Janak A Patel; Melinda Pettigrew; W Edward Swords
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04       Impact factor: 3.497

7.  Development of a LacZ-based transcriptional reporter system for use with Moraxella catarrhalis.

Authors:  Amanda S Evans; Christine Pybus; Eric J Hansen
Journal:  Plasmid       Date:  2012-12-04       Impact factor: 3.466

Review 8.  Bacterial-Host Interactions: Physiology and Pathophysiology of Respiratory Infection.

Authors:  A P Hakansson; C J Orihuela; D Bogaert
Journal:  Physiol Rev       Date:  2018-04-01       Impact factor: 37.312

9.  Identification of an outer membrane lipoprotein involved in nasopharyngeal colonization by Moraxella catarrhalis in an animal model.

Authors:  Wei Wang; Stephanie N Joslin; Christine Pybus; Amanda S Evans; Flora Lichaa; Chad A Brautigam; Eric J Hansen
Journal:  Infect Immun       Date:  2014-03-18       Impact factor: 3.441

10.  Use of the Chinchilla model to evaluate the vaccinogenic potential of the Moraxella catarrhalis filamentous hemagglutinin-like proteins MhaB1 and MhaB2.

Authors:  Teresa L Shaffer; Rachel Balder; Sean W Buskirk; Robert J Hogan; Eric R Lafontaine
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.